| The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 176, S21-S141, 2019 | 793 | 2019 |
| The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 178, S27-S156, 2021 | 494 | 2021 |
| An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81 K Ahmed, S Tunaru, C Tang, M Müller, A Gille, A Sassmann, J Hanson, ... Cell metabolism 11 (4), 311-319, 2010 | 449 | 2010 |
| The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017 | 314 | 2017 |
| Nicotinic acid–and monomethyl fumarate–induced flushing involves GPR109A expressed by keratinocytes and COX-2–dependent prostanoid formation in mice J Hanson, A Gille, S Zwykiel, M Lukasova, BE Clausen, K Ahmed, ... The Journal of clinical investigation 120 (8), 2910-2919, 2010 | 221 | 2010 |
| Coxibs and cardiovascular side-effects: from light to shadow JM Dogné, J Hanson, C Supuran, D Pratico Current pharmaceutical design 12 (8), 971-975, 2006 | 186 | 2006 |
| The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, AA Mathie, ... British Journal of Pharmacology 180, S23-S144, 2023 | 150 | 2023 |
| Insight into SUCNR1 (GPR91) structure and function J Gilissen, F Jouret, B Pirotte, J Hanson Pharmacology & therapeutics 159, 56-65, 2016 | 147 | 2016 |
| Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis JM Dogné, J Hanson, D Pratico Trends in pharmacological sciences 26 (12), 639-644, 2005 | 137 | 2005 |
| Formation, signaling and occurrence of specialized pro-resolving lipid mediators—what is the evidence so far? NH Schebb, H Kühn, AS Kahnt, KM Rund, VB O’Donnell, N Flamand, ... Frontiers in pharmacology 13, 838782, 2022 | 124 | 2022 |
| The G protein-coupled receptors deorphanization landscape C Laschet, N Dupuis, J Hanson Biochemical Pharmacology 153, 62-74, 2018 | 117 | 2018 |
| Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials M Lukasova, J Hanson, S Tunaru, S Offermanns Trends in pharmacological sciences 32 (12), 700-707, 2011 | 115 | 2011 |
| New developments on thromboxane and prostacyclin modulators part I: thromboxane modulators JM Dogné, X Leval, J Hanson, M Frederich, B Lambermont, A Ghuysen, ... Current medicinal chemistry 11 (10), 1223-1241, 2004 | 113 | 2004 |
| New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulators X Leval, J Hanson, JL David, B Masereel, B Pirotte, JM Dogné Current medicinal chemistry 11 (10), 1243-1252, 2004 | 110 | 2004 |
| Deorphanization of GPR109B as a receptor for the β-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis K Ahmed, S Tunaru, CD Langhans, J Hanson, CW Michalski, S Kölker, ... Journal of Biological Chemistry 284 (33), 21928-21933, 2009 | 99 | 2009 |
| The distinct roles of CXCR3 variants and their ligands in the tumor microenvironment N Reynders, D Abboud, A Baragli, MZ Noman, B Rogister, SP Niclou, ... Cells 8 (6), 613, 2019 | 85 | 2019 |
| From the design to the clinical application of thromboxane modulators JM Dogné, J Hanson, X Leval, D Pratico, CR Pace-Asciak, P Drion, ... Current pharmaceutical design 12 (8), 903-923, 2006 | 79 | 2006 |
| The causes and consequences of pituitary gigantism A Beckers, P Petrossians, J Hanson, AF Daly Nature Reviews Endocrinology 14 (12), 705-720, 2018 | 74 | 2018 |
| Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin J Hanson, A Gille, S Offermanns Pharmacology & therapeutics 136 (1), 1-7, 2012 | 68 | 2012 |
| Identification and pharmacological characterization of succinate receptor agonists P Geubelle, J Gilissen, S Dilly, L Poma, N Dupuis, C Laschet, D Abboud, ... British Journal of Pharmacology 174 (9), 796-808, 2017 | 65 | 2017 |
Dogne Jean-MichelProfessor at University of NamurAdresse e-mail validée de unamur.be
